Status:
UNKNOWN
Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Covid19
Hypercoagulable States Nec
Eligibility:
All Genders
18-80 years
Brief Summary
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is a pandemic, which has affected approximately 4 lakhs individuals and claimed 16,362 deaths till now. SARS-CoV-2 has been assoc...
Detailed Description
Several Consensus statements have been published in the literature in the last 2 months emphasizing the need for data in Covid 19 to assess the risk of both bleeding i.e. disseminated intravascular co...
Eligibility Criteria
Inclusion
- Age 18-80 years
- Confirmed Covid19 patient with positive RT PCR
Exclusion
- Current therapy: Recent blood or blood component transfusion in the last 2 weeks.
- HIV positive/ AIDS patients
- Pregnancy
- Active malignancy within the last 5 years
- Not willing to participate in the study
Key Trial Info
Start Date :
August 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04668404
Start Date
August 24 2020
End Date
February 1 2021
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PGIMER
Chandigarh, India, 160012